Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran, Reju George Thomas, Myeong Ju Moon, Yong Yeon Jeong Department of Radiology, BioMolecular Theranostics (BiT) Lab, Chonnam National University Medical School, Chonnam National University Hwasun Hospital (CNUHH), South Korea Abstract: Chronic liver diseases repre...
Guardado en:
Autores principales: | Poilil Surendran S, George Thomas R, Moon MJ, Jeong YY |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/558918bce01243c98ed8b407583a9daa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Research progress on the application of nanoparticle drug delivery systems in local drug treatment of periodontitis
por: ZHANG Xinjian, et al.
Publicado: (2022) -
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
por: Zhang W, et al.
Publicado: (2018) -
CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGFβ-induced HSC-T6 cells activation
por: Ullah A, et al.
Publicado: (2019) -
AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
por: Xin J, et al.
Publicado: (2018) -
Spermidine-mediated poly(lactic-co-glycolic acid) nanoparticles containing fluorofenidone for the treatment of idiopathic pulmonary fibrosis
por: Tang J, et al.
Publicado: (2017)